Tagrisso FDA Approved Drugs
TAGRISSO [Osimertinib MesylateC28H33N7O2CH4O3S]
RX
- eq 40mg base (oral tablet)
eq 80mg base (oral tablet)
Astrazeneca PharmsNov 13, 2015
- Treatment of patients with metastatic epidermal growth factore receptor (egfr) t790m mutation-positive non-small cell lung cancer (nsclc), who have progressed on or after egfr tki therapy.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.